Pfizer-BioNTech has entered late-stage clinical trials of their coronavirus vaccine in children between ages five and 11. Pfizer-BioNTech announced on Tuesday they have begun late-stage clinical trials of their coronavirus vaccine in children ages five to 11. Pictured: Pfizer announces the late-stage clinical trials in childrenAccording to clinicaltrials.gov, Pfizer's study in younger children will work similarly to the way it did in older children and adults. Among the participants are siblings Russell Bright, age seven, and Tucker Bright, age five, who are being tested at Ochsner Medical Center, just outside New Orleans in Louisiana. In fact, Pfizer announced that it selected lower doses for COVID-19 vaccine trials in children than are given to teenagers and adults.

Source: Daily Mail June 08, 2021 13:59 UTC